In North America, the Helicobacter Pylori diagnostics market is expected to witness steady growth due to the rising prevalence of H. pylori infection in the region. The United States and Canada are the main countries contributing to the market growth. The increasing awareness about the complications associated with untreated H. pylori infection, such as peptic ulcers and gastric cancer, is driving the demand for diagnostics tests in the region.
Asia Pacific:
In Asia Pacific, the Helicobacter Pylori diagnostics market is projected to experience substantial growth, particularly in countries like China, Japan, and South Korea. The high prevalence of H. pylori infection in these countries, coupled with the increasing adoption of advanced diagnostic technologies, is anticipated to fuel market growth. Additionally, the growing healthcare expenditure and rising awareness about gastrointestinal diseases are driving the demand for H. pylori diagnostics in the region.
Europe:
In Europe, the Helicobacter Pylori diagnostics market is expected to grow steadily, with countries like the United Kingdom, Germany, and France leading the market. The increasing prevalence of H. pylori infection in Europe, along with the rising geriatric population prone to gastrointestinal disorders, is driving the demand for diagnostic tests. Moreover, the presence of well-established healthcare infrastructure and the availability of advanced diagnostic technologies are further contributing to market growth in the region.